tiprankstipranks
Aerovate Therapeutics (AVTE)
NASDAQ:AVTE
US Market

Aerovate Therapeutics (AVTE) Technical Analysis

80 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
3Neutral
13Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Aerovate Therapeutics’s (AVTE) Moving Averages Convergence Divergence (MACD) indicator is -1.24, suggesting Aerovate Therapeutics is a Buy.
Aerovate Therapeutics’s (AVTE) 20-Day exponential moving average is 21.57, while Aerovate Therapeutics’s (AVTE) share price is $19.28, making it a Sell.
Aerovate Therapeutics’s (AVTE) 50-Day exponential moving average is 22.62, while Aerovate Therapeutics’s (AVTE) share price is $19.28, making it a Sell.

Aerovate Therapeutics (AVTE) Pivot Points

May 14, 2024, 09:51 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
16.96
18.27
19.05
20.37
21.14
22.46
23.24
Fibonacci
18.27
19.07
19.56
20.37
21.17
21.66
22.46
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aerovate Therapeutics (AVTE) Moving Averages

May 14, 2024, 09:51 PM
Period
Simple
Exponential
MA5
20.40Sell
20.13Sell
MA10
20.45Sell
20.59Sell
MA20
21.24Sell
21.57Sell
MA50
24.30Sell
22.62Sell
MA100
22.31Sell
21.73Sell
MA200
18.21Buy
19.39Sell
Aerovate Therapeutics’s (AVTE) 10-Day exponential moving average is 20.59, while Aerovate Therapeutics’s (AVTE) share price is $19.28, making it a Sell.
Aerovate Therapeutics’s (AVTE) 100-Day exponential moving average is 21.73, while Aerovate Therapeutics’s (AVTE) share price is $19.28, making it a Sell.
Aerovate Therapeutics’s (AVTE) stock price is $19.28 and Aerovate Therapeutics’s (AVTE) 50-day simple moving average is 24.30, creating a Sell signal.
Aerovate Therapeutics’s (AVTE) stock price is $19.28 and Aerovate Therapeutics’s (AVTE) 100-day simple moving average is 22.31, creating a Sell signal.
Aerovate Therapeutics’s (AVTE) stock price is $19.28 and Aerovate Therapeutics’s (AVTE) 200-day simple moving average is 18.21, creating a Buy signal.

Aerovate Therapeutics (AVTE) Technical Indicators

May 14, 2024, 09:51 PM
Name
Value
Implied Action
RSI (14)
36.05
Neutral
STOCH (9,6)
29.58
Neutral
STOCHRSI (14)
18.59
Buy
MACD (12,26)
-1.24
Buy
ADX (14)
16.40
Buy
Williams %R
-93.98
Buy
CCI (14)
-155.69
Buy
ATR (14)
1.73
-
Ultimate Oscillator
42.25
Neutral
ROC
-17.57
Sell
Aerovate Therapeutics’s (AVTE) Relative Strength Index (RSI) is 36.05, creating a Neutral signal.
Aerovate Therapeutics’s (AVTE) Trend Strength Indicator (ADX) is 16.40, creating a Buy signal.
Aerovate Therapeutics’s (AVTE) Commodity Channel Index (CCI) is -155.69, creating a Buy signal.
Aerovate Therapeutics’s (AVTE) Price Rate of Change (ROC) is -17.57, creating a Sell signal.

FAQ

Is AVTE a Buy, Hold, or Sell?
Based on AVTE’s technical indicators, AVTE is a Sell.
    What is AVTE’s RSI (14)?
    AVTE’s RSI (14) is 36.05, which suggests AVTE is a Neutral.
      What is AVTE’s MACD?
      AVTE’s MACD is -1.24, which suggests AVTE is a Buy.
        What is AVTE’s 5-day moving average?
        AVTE’s 5-day moving average is 20.40, which suggests AVTE is a Sell.
          What is AVTE’s 20-day moving average?
          AVTE 20-day moving average is 21.24, which suggests AVTE is a Sell.
            What is AVTE’s 50-day moving average?
            AVTE’s 50-day moving average is 24.30, which suggests AVTE is a Sell.
              What is AVTE’s 200-day moving average?
              AVTE’s 200-day moving average is 18.21, which suggests AVTE is a Buy.
                What is AVTE’s Williams % R (14)?
                AVTE’s Williams % R (14) is -93.98, which suggests AVTE is a Buy.
                  What is AVTE’s CCI (14)?
                  AVTE’s CCI (14) is -155.69, which suggests AVTE is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis